Ocular Therapeutix Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
772.00
1,750.00
1,887.00
1,923.00
1,990
Cost of Goods Sold (COGS) incl. D&A
404.00
638.00
1,073.00
883.50
2,082.00
2,751
Gross Income
404.00
134.00
677.00
1,003.50
159.00
761
SG&A Expense
12,499.00
27,228.00
38,874.00
44,329.50
59,258.00
58,357
EBIT
12,903.00
27,094.00
38,197.00
43,326.00
59,417.00
59,118
Unusual Expense
-
57.00
-
-
2,506.00
-
Non Operating Income/Expense
14.00
385.00
7.00
1.00
5.00
-
Interest Expense
441.00
1,119.00
1,724.00
1,680.00
1,892.00
1,739
Pretax Income
13,317.00
28,648.00
39,748.00
44,703.00
63,386.00
59,978
Consolidated Net Income
13,344.00
28,648.00
39,748.00
44,703.00
63,386.00
59,978
Net Income
13,344.00
28,648.00
39,748.00
44,703.00
63,386.00
59,978
Net Income After Extraordinaries
13,344.00
28,648.00
39,748.00
44,703.00
63,386.00
59,978
Net Income Available to Common
13,344.00
28,659.00
39,748.00
44,703.00
63,386.00
59,978
EPS (Basic)
0.63
2.69
1.71
1.80
2.20
1.57
Basic Shares Outstanding
21,322.40
10,652.90
23,244.20
24,816.30
28,818.20
38,115.10
EPS (Diluted)
0.63
2.69
1.71
1.80
2.20
1.57
Diluted Shares Outstanding
21,322.40
10,652.90
23,244.20
24,816.30
28,818.20
38,115.10
EBITDA
12,499.00
26,547.00
37,443.00
42,445.00
57,792.00
56,832
Non-Operating Interest Income
13.00
7.00
166.00
304.00
424.00
879
Other After Tax Income (Expense)
27.00
-
-
-
-
-
Preferred Dividends
-
11.00
-
-
-
-
About Ocular Therapeutix
View Profile
